InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

CMPX Stock Earnings: Compass Therapeutics Meets EPS for Q2 2024

By InvestorPlace Earnings

CMPX stock results show that Compass Therapeutics met analyst estimates for earnings per share the second quarter of 2024.

INDP Stock Earnings: Indaptus Therapeutics Beats EPS for Q2 2024

By InvestorPlace Earnings

INDP stock results show that Indaptus Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

IBRX Stock Earnings: ImmunityBio Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

MAMO Stock Earnings: Massimo Reported Results for Q2 2024

By InvestorPlace Earnings

Massimo just reported results for the second quarter of 2024.

APGE Stock Earnings: Apogee Therapeutics Meets EPS for Q2 2024

By InvestorPlace Earnings

APGE stock results show that Apogee Therapeutics met analyst estimates for earnings per share the second quarter of 2024.

Load More